<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Therapy</journal-id><journal-title-group><journal-title xml:lang="en">Therapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапия</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2412-4036</issn><issn publication-format="electronic">2713-1823</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">288745</article-id><article-id pub-id-type="doi">10.18565/therapy.2022.1.21-27</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Ways to optimize the prediction of fatal and nonfatal cases of stroke in patients with peripheral atherosclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Пути оптимизации прогнозирования фатальных и нефатальных случаев инсульта у больных с периферическим атеросклерозом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kobzeva</surname><given-names>Natalia D.</given-names></name><name xml:lang="ru"><surname>Кобзева</surname><given-names>Наталия Дмитриевна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, assistant at the Department of internal diseases No. 1</p></bio><bio xml:lang="ru"><p>к.м.н., ассистент кафедры внутренних болезней № 1</p></bio><email>kobzeva.nataliya10gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Martynov</surname><given-names>Anatoly I.</given-names></name><name xml:lang="ru"><surname>Мартынов</surname><given-names>Анатолий Иванович</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, academician of RAS, professor of the Department of hospital therapy No. 1</p></bio><bio xml:lang="ru"><p>д.м.н., академик РАН, профессор кафедры госпитальной терапии № 1</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Terentiev</surname><given-names>Vladimir P.</given-names></name><name xml:lang="ru"><surname>Терентьев</surname><given-names>Владимир Петрович</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, professor, head of the Department of internal diseases No. 1</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, зав. кафедрой внутренних болезней № 1</p></bio><email>vpterentev0mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Rostov State Medical University of the Ministry of Healthcare of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Ростовский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2022</year></pub-date><volume>8</volume><issue>1</issue><issue-title xml:lang="en">VOL 8, NO1 (2022)</issue-title><issue-title xml:lang="ru">ТОМ 8, №1 (2022)</issue-title><fpage>21</fpage><lpage>27</lpage><history><date date-type="received" iso-8601-date="2023-02-26"><day>26</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, “Bionika Media” LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО «Бионика Медиа»</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">“Bionika Media” LLC</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://journals.eco-vector.com/2412-4036/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2412-4036/article/view/288745">https://journals.eco-vector.com/2412-4036/article/view/288745</self-uri><abstract xml:lang="en"><p>Recently, there has been a significant increase in interest in research aimed at predicting cardiovascular risk in individuals with peripheral atherosclerosis. Aim: to study the effect of atherosclerotic lesions of various vascular basins on long-term prognosis and optimization of prediction of fatal and non-fatal cases of stroke in patients with peripheral atherosclerosis. Material and methods. The study included 519 patients with lesions of various vascular basins, who were treated in specialized departments. The average age of the examined patients was 60.0±8.7 years. Results. In the course of two-factor logistic regression analysis, we obtained a complex of factors that influence the risk of developing nonfatal cases of stroke, namely, «chronic ischemia of the lower limb + abdominal aorta» (p=0.043), «amputation of the lower limb in history + chronic ischemia of the lower limbs» (p=0.017). Conclusions. Original nomograms have been developed to assess the risk of stroke in patients with peripheral atherosclerosis.</p></abstract><trans-abstract xml:lang="ru"><p>В последнее время значительно возрос интерес к исследованиям, направленным на прогнозирование сердечно-сосудистого риска у лиц с периферическим атеросклерозом. Цель - изучение влияния атеросклеротического поражения различных сосудистых бассейнов на отдаленный прогноз и оптимизация прогнозирования фатальных и нефатальных случаев инсульта у больных с периферическим атеросклерозом. Материал и методы. В исследование включено 519 пациентов с поражением различных сосудистых бассейнов, находившихся на лечении в профильных отделениях. Средний возраст обследованных больных составил 60,0±8,7лет. Результаты. В ходе двухфакторного логистического регрессионного анализа нами был получен комплекс факторов, оказывающих свое влияние на риск развития нефатальных случаев инсульта, а именно «хроническая ишемия нижней конечности (ХИНК) + атеросклеротическое поражение брюшного отдела аорты» (р=0,043), «ампутация нижней конечности в анамнезе + ХИНК» (р=0,017). Заключение. Разработаны оригинальные номограммы для оценки риска инсульта у больных с периферическим атеросклерозом.</p></trans-abstract><kwd-group xml:lang="en"><kwd>peripheral atherosclerosis</kwd><kwd>fatal and nonfatal stroke</kwd><kwd>prospective observation</kwd><kwd>long-term prognosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>периферический атеросклероз</kwd><kwd>фатальный и нефатальный инсульт</kwd><kwd>проспективное наблюдение</kwd><kwd>отдаленный прогноз</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Бойцов С.А., Демкина А.Е., Ощепкова Е.В., Долгушева Ю.А. Достижения и проблемы практической кардиологии в России на современном этапе. Кардиология. 2019; 3: 53-59</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kobzeva N., Terentiev V., Zolotukhina I. The use of statistical analysis methods in assessing long-term prognoses in patients with acute coronary syndrome and contrast-induced nephropathy. IOP Conference Series: Materials Science and Engineering. 2019; 680(1): 012011. https://dx.doi.org/10.1088/1757-899X/680/1/012011.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Bonaca M.P., Gutierrez J.A., Creager M.A. et al. Acute limb ischemia and outcomes with vorapaxar in patients with peripheral artery disease: Results from the trial to assess the effects of vorapaxar in preventing heart attack and stroke in patients with atherosclerosis-thrombolysis in myocardial infarction. Circulation. 2016; 133(10): 997-1005. https://dx.doi.org/10.1161/CIRCULATIONAHA.115.019355.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Madeira S., Rodrigues R., Tralhao A. et al. Assessment of perioperative mortality risk in patients with infective endocarditis undergoing cardiac surgery: Performance of the EuroSCORE I and II logistic models.Interact Cardiovasc Thorac Surg. 2016; 22(2): 141-48. https://dx.doi.org/10.1093/icvts/ivv304.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Fearon W.F., Nishi T., De Bruyne B. et al. Clinical outcomes and costeffectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: Three-year follow-up of the FAME 2 trial (Fractional flow reserve versus Angiography for Multivessel Evaluation). Circulation. 2018; 137(5): 480-87. https://dx.doi.org/10.1161/CIRCULATIONAHA.117.031907.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Zhang J., Dong Z., Liu P. et al. Different strategies in simultaneous coronary and carotid artery revascularization - a single center experience. Arch Iran Med. 2019; 22(3): 132-36.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Кобзева Н.Д. Особенности влияния атеросклеротического поражения различных сосудистых бассейнов на риск развития фатальных и нефатальных событий в отдаленном периоде. Терапия. 2021; 8: 70-75</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Рекомендации ЕОК/ЕОСХ по диагностике и лечению заболеваний периферических артерий 2017. Российский кардиологический журнал. 2018; 8: 164-221</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Knuuti J., Wijns W., Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407-77. https://dx.doi.org/10.1093/eurheartj/ehz425.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gerhard-Herman M.D., Gornik H.L., Barrett C. et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017; 135(12): 686-725. https://dx.doi.org/10.1161/CIR.0000000000000470.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Saha T., Naqvi S.Y., Ayah O.A. et al. Subclavian artery disease: Diagnosis and therapy. Am J Med. 2017; 130(4): 409-16. https://dx.doi.org/10.1016/j.amjmed.2016.12.027.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Фенкель В.В., Шапошник И.И. Показатели эндотелиальной скорости сдвига в сонной артерии как маркер системного атеросклероза и сердечно-сосудистых заболеваний, обусловленных атеросклерозом. Кардиология. 2019; 5: 45-52</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Xing R., Moerman A.M., Ridwan Y. et al. Temporal and spatial changes in wall shear stress during atherosclerotic plaque progression in mice. R Soc Open Sci. 2018; 5(3): 171447. https://dx.doi.org/10.1098/rsos.171447.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Maruhashi T., Soga J., Fujimura N. et al. Brachial artery diameter as a marker for cardiovascular risk assessment: FMD-J study. Atherosclerosis. 2018; 268: 92-98. https://dx.doi.org/10.1016/j.atherosclerosis.2017.11.022.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Погосова Н.В., Юферева Ю.М., Качанова Н.П. с соавт. Разработка алгоритма диагностики доклинического атеросклероза у пациентов из группы высокого риска развития сердечно-сосудистых заболеваний. Кардиология. 2020; 2: 75-82.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Губарева М.Ю., Малышев П.П., Аншелес А.А., Сергиенко И.В. Оценка факторов риска развития атеросклероза у лиц различных категорий риска развития сердечно-сосудистых заболеваний при использовании калькулятора Aterostop. Кардиология. 2021; 3: 12-17</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kotseva K., De Backer G., De Bacquer D. et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019; 26(8): 824-35. https://dx.doi.org/10.1177/2047487318825350</mixed-citation></ref></ref-list></back></article>
